Nautilus Biotechnology, Inc. (NAUT) Tops Q3 EPS by 4c

Nautilus Biotechnology, Inc. (NASDAQ: NAUT) reported Q3 EPS of ($0.13), $0.04 better than the analyst estimate of ($0.17).

For earnings history and earnings-related data on Nautilus Biotechnology, Inc. (NAUT) click here.

You May Also Be Interested In

• Infleqtion raises Q2 revenue to $13.5M after contract restatement
• DocGo (DCGO) Misses Q2 EPS by 6c; Offers Guidance
• Stifel Canada Starts Cadillac Mines Corp (CADY:CN) at Buy